SNCA,MAPT, andGSK3Bin Parkinson disease: a gene-gene interaction study - sprookjes - yvandenbroek - TriplyDB

SNCA,MAPT, andGSK3Bin Parkinson disease: a gene-gene interaction study

SNCA,MAPT, andGSK3Bin Parkinson disease: a gene-gene interaction study

http://www.wikidata.org/entity/Q57983208

about

The regulation and deregulation of Wnt signaling by PARK genes in health and disease GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein Alpha-synuclein and tau: teammates in neurodegeneration?Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson's Disease Assessed by the Unified Parkinson's Disease Rating Scale and the Hoehn-Yahr Stage Neurodevelopment in schizophrenia: the role of the wnt pathways.MAPT rs242562 and GSK3B rs334558 are associated with Parkinson's Disease in central China.Variants in SNCA Gene Are Associated with Parkinson's Disease Risk and Cognitive Symptoms in a Brazilian Sample.H1-MAPT and the risk for familial essential tremor Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications.SNP-SNP Interaction between TLR4 and MyD88 in Susceptibility to Coronary Artery Disease in the Chinese Han Population.LRRK2: an éminence grise of Wnt-mediated neurogenesis?Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.Genetic variability in SNCA and Parkinson's disease.Genetic Variants in SNCA and the Risk of Sporadic Parkinson's Disease and Clinical Outcomes: A Review SNCA rs356219 variant increases risk of sporadic Parkinson's disease in ethnic Chinese.GSK3β reduces risk of sporadic Parkinson's disease in ethnic Chinese.Metformin Inhibits the Development of L-DOPA-Induced Dyskinesia in a Murine Model of Parkinson's Disease.MAPT1 gene rs1052553 variant is unrelated with the risk for restless legs syndrome.Interaction between SNCA, LRRK2 and GAK increases susceptibility to Parkinson's disease in a Chinese population.

P2860

Q26991986-592C287D-C111-40E4-9708-F7E2100BBE74 Q27331743-1596EDB4-31E5-4E6E-974A-B5E587A85F4B Q28250508-09EE6282-05FC-4E69-9EAC-5B0C8EB90075 Q28396892-E5E10E0B-E79E-4086-B815-8B5DB643CBF4 Q30442237-02E985C8-DD21-4B6F-891B-11ED11276BF2 Q33611508-3B286E7F-7921-408E-8CC2-3C4F80B09F6B Q33813336-12E90AAB-F20E-4A73-8135-F68C721BF266 Q34388030-A26F55BB-EA8D-4B25-B9EA-DBE1BAEF0437 Q36086872-3D37B235-3C8C-4D05-9CD9-0BBB3647A126 Q36732348-909B0012-E801-446E-B5B3-CD18F10D5C63 Q36888947-E0F003F7-DFF3-476E-9337-8827768FE618 Q37312762-6DCFD775-A0DB-4DED-AE8F-75CF1C1A01F4 Q37907930-D588DC2B-7D49-4F5C-A9BB-5F6D614AAE56 Q38637878-DC9D3B54-267A-4F14-9BB4-B4E8C0B494D0 Q43521013-4BCB084F-C955-4157-81E7-8313B257C502 Q44577082-FCCF7987-955D-4541-9D33-579C93327C2F Q48177380-98646067-A599-4370-94AC-508F069BC163 Q54290859-CE41885E-9E4B-4039-9A92-5575A81B702E Q54988601-111065EF-6A55-410C-B002-D41238A1B2DE

P2860

SNCA,MAPT, andGSK3Bin Parkinson disease: a gene-gene interaction study

http://www.wikidata.org/entity/Q57983208

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в грудні 2010

@uk

name

SNCA,MAPT, andGSK3Bin Parkinson disease: a gene-gene interaction study

@en

SNCA,MAPT, andGSK3Bin Parkinson disease: a gene-gene interaction study

@nl

type

label

SNCA,MAPT, andGSK3Bin Parkinson disease: a gene-gene interaction study

@en

SNCA,MAPT, andGSK3Bin Parkinson disease: a gene-gene interaction study

@nl

prefLabel

SNCA,MAPT, andGSK3Bin Parkinson disease: a gene-gene interaction study

@en

SNCA,MAPT, andGSK3Bin Parkinson disease: a gene-gene interaction study

@nl

P1433

Q57983208-115054B2-D096-49DD-8796-59A4049AAD75

P1476

Q57983208-997C0BF8-4456-4F8F-AC9B-CF3904CECC5C

P2093

Q57983208-3A3E3E5A-BE25-4632-8C2F-73FB31261590

Q57983208-4351B1D4-8E34-4B0F-9DAC-5D2157A3A56F

Q57983208-4A8E4110-1417-4248-ABD6-4FB78230CDA2

Q57983208-4D537372-FE80-4428-8CBE-BC4DF1D2BBCA

Q57983208-7558E5CB-795D-4D4F-BDFF-57D65EFF738C

Q57983208-79205161-0074-4002-9649-E806B75E5B92

Q57983208-7F63FFE0-5CFD-4B60-B81C-3659DF776A2C

Q57983208-8BD3158F-7396-4A8E-8080-AFC2062EF29F

Q57983208-A00A8DA6-0EB9-4699-84AB-D6D2DAC55A14

Q57983208-B6CCE888-CBB2-4BC6-865A-B484B4C71EFE

P2860

Q57983208-0E1C1618-0030-4CD6-9AEC-07253D99E502

Q57983208-0F640297-FEEE-438B-93F9-7E5DCDB956F3

Q57983208-2388ED00-00E3-418A-96C2-4E344A566243

Q57983208-24A38404-1B47-406A-927D-23576C1A0D73

Q57983208-251DA4F1-AEBC-4339-A394-319042B5D285

Q57983208-4B3E4683-BFF0-4450-8AE5-3D6142809DF2

Q57983208-4BAF12FD-C748-44A0-B6D1-5D75E90D4650

Q57983208-728A4CF9-4E60-40E5-A450-0D5DC8A696BA

Q57983208-785E9D70-E274-4CDF-8C8A-BCAE866C5C14

Q57983208-79485A62-D78C-43D9-9F3D-4A82FC59FABC

P304

Q57983208-487E7516-AB2E-412C-B469-DF3B1D350363

P31

Q57983208-8CB4EB04-680D-4B88-B428-0F3B3E0A9A3B

P356

Q57983208-EF446E16-6E3B-441D-AF2E-E114504816F3

P433

Q57983208-19929AD1-534C-452B-A408-FFD0D063D520

P478

Q57983208-891643AB-7DEB-4193-8778-DC3C3519E6EF

P50

Q57983208-1F553EF9-4FF6-47E7-955F-C0E7007A2490

Q57983208-D3CB6A5E-5FAF-4BA3-A755-1FE53099D82E

P577

Q57983208-615B7B9D-FEC9-47DA-94AA-6DF47DC36A04

P698

Q57983208-7AB4CFD2-9F20-48D0-9A01-D45F5BB29942

P921

Q57983208-D1B92C0A-EDD2-4C54-9F2A-18C7F8A3EFAB

P356

J.1468-1331.2010.03297.X

P1433

European Journal of Neurology

P1476

SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study

@en

P2093

A I Ortolaza-Soto

http://www.w3.org/2001/XMLSchema#string

B Jasinska-Myga

http://www.w3.org/2001/XMLSchema#string

C Wider

http://www.w3.org/2001/XMLSchema#string

J A Bacon

http://www.w3.org/2001/XMLSchema#string

J E Crook

http://www.w3.org/2001/XMLSchema#string

J M Gibson

http://www.w3.org/2001/XMLSchema#string

J O Aasly

http://www.w3.org/2001/XMLSchema#string

M G Heckman

http://www.w3.org/2001/XMLSchema#string

N N Diehl

http://www.w3.org/2001/XMLSchema#string

O A Ross

http://www.w3.org/2001/XMLSchema#string

P2860

Parkinson's disease: from monogenic forms to genetic susceptibility factors

Interface between tauopathies and synucleinopathies: A tale of two proteins

Genome-wide association study reveals genetic risk underlying Parkinson's disease

GSK3B polymorphisms alter transcription and splicing in Parkinson's disease

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease

The glamour and gloom of glycogen synthase kinase-3

Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models.

Tau and synuclein and their role in neuropathology.

Diagnostic criteria for Parkinson disease.

P304

876-881

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1468-1331.2010.03297.X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Carles Vilariño-Güell

Matthew J. Farrer

P577

2010-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21159074

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease